Streetbeat News

Stock Prices

ATER

RIDE

XELB

XPOF

During Tuesday's intraday session, several consumer discretionary stocks experienced significant movement. Gainers included Xcel Brands (XELB), Aterian (ATER), Cooper-Standard Holdings (CPS), Carvana (CVNA), NIO (NIO), and RumbleON (RMBL). Losers included Xponential Fitness (XPOF), Lordstown Motors (RIDE), Mullen Automotive (MULN), Greenlane Hldgs (GNLN), ECARX Holdings (ECX), and GreenTree Hospitality Gr (GHG).

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:37 pm

ACET

BDTX

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Black Diamond Therapeutic (BDTX), Tivic Health Systems (TIVC), CalciMedica (CALC), Belite Bio (BLTE), MoonLake (MLTX), and Genelux (GNLX) saw their stocks rise, with BDTX leading the gainers with a 238.5% increase. On the other hand, Adicet Bio (ACET), Nkarta (NKTX), Terns Pharma (TERN), BioRestorative Therapies (BRTX), Viking Therapeutics (VKTX), and Benitec Biopharma (BNTC) experienced declines, with ACET leading the losers with a 53.6% decrease.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:37 pm

DAL

JBLU

JetBlue Airways shares are trading higher following Delta Air Lines' raised Q2 and 2023 guidance at its Investor Day presentation.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2023 | 5:37 pm

DAL

JBLU

JetBlue Airways Corporation (JBLU) shares are trading higher by 9.69% to $8.83, potentially in sympathy with Delta Air Lines, Inc. (DAL) which raised its Q2 and 2023 guidance at its Investor Day presentation. Delta Air Lines anticipates revenue growth of 17%-18% for Q2 2023, up from the previous forecast of 15%-17%, and an EPS in the range of $2.25-$2.50, surpassing the consensus estimate of $2.17.

Portfolio Pulse from Henry Khederian

June 27, 2023 | 5:36 pm

BABA

PDD

Bernstein analyst Robin Zhu has downgraded Alibaba Group Holding Ltd (BABA) from Outperform to Market Perform, lowering the price target from $130 to $98. The downgrade is due to persistent low growth and merchant crowding issues. Alibaba's shares have traded in a range despite its cheap valuation. The company's large number of active merchants, almost double that of PDD Holdings Inc (PDD), is driving up search costs and putting pressure on merchant ROI. Concerns also exist about the Cloud spin-off due to potential U.S. sanction risk.

Portfolio Pulse from Anusuya Lahiri

June 27, 2023 | 5:32 pm

EQIX

Equinix Inc.'s shares have increased by 5.93% in the past three months. The company's total debt stands at $15.63 billion, with $15.47 billion in long-term debt and $165.32 million in current debt. After adjusting for $2.64 billion in cash-equivalents, the net debt is $12.99 billion. Equinix has $31.27 billion in total assets, making the debt-ratio 0.5. Debt is an important factor in a company's capital structure and contributes to its growth.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:31 pm

JPM

Over the past 15 years, JPMorgan Chase (NYSE:JPM) has outperformed the market by 1.14% on an annualized basis, producing an average annual return of 9.74%. If an investor had bought $100 of JPM stock 15 years ago, it would be worth $410.07 today.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:30 pm

ITW

Illinois Tool Works (NYSE:ITW) has outperformed the market over the past 20 years, producing an average annual return of 10.58%. If an investor had bought $100 of ITW stock 20 years ago, it would be worth $760.28 today. The company currently has a market capitalization of $75.84 billion.

Portfolio Pulse from Benzinga Insights

June 27, 2023 | 5:30 pm

NVDA

SNOW

TSLA

TSM

Nvidia Corp (NVDA) is benefiting from the artificial intelligence boom, with Snowflake Inc (SNOW) using Nvidia's technology for AI applications and a strong demand for Nvidia GPUs in China. However, Tesla Inc (TSLA) is planning to reduce its reliance on Nvidia by developing its own AI chips. Despite the positive outlook, a finance professor at NYU values Nvidia's shares at $240, well below the current price of $415.08.

Portfolio Pulse from Anusuya Lahiri

June 27, 2023 | 5:26 pm

NKTX

Nkarta Inc (NASDAQ:NKTX) announced updated data from the Phase 1 study of NKX101 for treating acute myeloid leukemia (AML). The results showed a 67% complete response rate in one cohort and a 22% complete response rate in another. However, the company's shares fell by 34.20% following the announcement.

Portfolio Pulse from Vandana Singh

June 27, 2023 | 5:23 pm